RxDoctor Payments Data

Stephen Smith, MD

Pain Medicine · Chesterfield, MONPI 1811988942

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $148 and has fallen 89.5% since, to $15 in 2024. That places this record below the midpoint for pain medicine clinicians in MO, where the typical reported total is $2,454.

$218in general payments, 2019–2025

Across 15 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$51
  • Medtronic$47
  • Abbott$28
  • Radius Health, Inc.$28
  • Sun Pharmaceutical Industries Inc.$21
  • Scilex Pharmaceuticals Inc.$17
  • plus $26 from 2 others
$5,097in research payments, 2019–2025

Across 4 payments — averaging $1274.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$5K

What the payments were for

  • Food & beverage$218100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$218 in reported general payments places this provider in the 15th percentile of 124 pain medicine providers in Missouri.

See all pain medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$268,443
Medicare patients
322
Services billed
11,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen215$3,106
Gabapentin237$2,841
Pregabalin70$1,847
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen58$1,270
Tramadol Hcl194$1,022
Oxycodone Hcl13$150
Methylprednisolone27$136
Metoclopramide Hcl127$97
Cyclobenzaprine Hcl14$67
Omeprazole50$63
Cephalexin11$54
Meloxicam12$30

Paid to pharmacies, not to this prescriber.

Other pain medicine in Chesterfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →